Piper Jaffray steps down from the sidelines amid hurricane haze, bracing for rocky 3Q results from FINL.
Can These Biotech Stocks Recover from an FDA Setback and a Stark 2Q Preliminary Earnings Stumble?
Today’s only report was bad once again. Markit’s PMI preliminary report for September was 51.
With the ink dry on a record-breaking 2016 NBA finals, Piper Jaffray analyst Erinn Murphy weighs in on athletic retailer giants Nike Inc …
